<DOC>
	<DOCNO>NCT01785862</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety repeat dos low dosage oromucosal Ibuprofen form ( lozenge ) versus placebo patient suffer acute sore throat pain .</brief_summary>
	<brief_title>Ibuprofen Lozenge Acute Sore Throat Pain</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>male female age least 18 year old patient acute sore throat Severe respiratory tract infection ( pneumonia , bronchitis laryngitis ) Oropharyngeal paresthesia mycosis Severely traumatise and/or severe oromucosal inflammation Tonsillopharyngectomy Peritonsillar abscess Hypersensitivity ibuprofen NonSteroidal AntiInflammatory Drugs ( NSAIDs ) ( include bronchospasm ) excipients Long term use ( â‰¥ 3 time per week within last month regular intake within last 3 month randomisation ) antiinflammatory drug Any longacting slow release analgesic intake include NonSteroidal AntiInflammatory Drugs ( NSAIDs ) within 24 hour randomisation ( e.g . piroxicam naproxen ) Any antiinflammatory drug intake systemic route within 12 hour randomisation Any paracetamol intake within 6 hour randomisation Any cold medication ( decongestant , antihistamine , expectorant , antitussive ) within 6 hour randomisation Any topical throat medication intake contain local oral anaesthetic lozenge , spray , mouth rinse within 4 hour randomisation Heavy smoker ( &gt; 20 cigarettes/day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>sore throat pain</keyword>
	<keyword>tonsillopharyngitis</keyword>
	<keyword>upper respiratory tract infection</keyword>
</DOC>